Browse every story filed under this topic, curated from trusted publishers around the world.
FDA launches ‘real-time’ clinical trials
The FDA has launched its first two real-time clinical trials in partnership with Houston-based University of Texas MD Anderson Cancer Center, Philadelphia-based University of Pennsylvania, AstraZeneca, Amgen and Paradigm Health. The real-time clinical trial model allows …
Read full story →FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
The FDA has released briefing documents detailing its concerns for AstraZeneca’s cancer drugs camizestrant and Truqap ahead of an upcoming …
AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has passed another crucial milestone as …
FDA approves AstraZeneca’s Saphnelo for SLE
AstraZeneca has received approval from the FDA for the subcutaneous self-administration of Saphnelo using the Saphnelo pen for SLE.
AstraZeneca to seek accelerated approval of Ultomirisin in IgAN on Phase III data
AstraZeneca’s rare disease company Alexion said the IgAN trial met its first co-primary endpoint. The post AstraZeneca to seek accelerated …
AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win
In a phase 3 trial in the rare kidney disease IgAN, AstraZeneca said its Ultomiris delivered a clinically meaningful and …
AstraZeneca’s COPD drug gains third Phase III win
Positive data from AstraZeneca's MIRANDA trial follows the OBERON and TITANIA studies of tozorakimab in COPD. The post AstraZeneca’s COPD …
You've seen all articles for #astrazeneca.
Check back
soon
for new stories.